In modern immunology and vaccine development, antigens alone are rarely sufficient to elicit robust, long-lasting protection. The quality, magnitude, and persistence of immune responses are critically shaped by adaptive immunity adjuvants—specialized components designed to enhance antigen-specific T-cell and B-cell responses. As global health challenges evolve and therapeutic...